The reduced sensation of dyspnea during exercise by inhaled oxitropium bromide in severe COPD patients.
Teramoto
S
S
Fukuchi
Y
Y
D004417:Dyspnea / Q000188:drug therapy*; D015444:Exercise / Q000502:physiology*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology*; D010276:Parasympatholytics / Q000627:therapeutic use*; D012129:Respiratory Function Tests; D012602:Scopolamine Derivatives / Q000627:therapeutic use*
D010276:Parasympatholytics; D012602:Scopolamine Derivatives; C017590:oxitropium